June CH - Search Results

1

Young RM, Engel NW, Uslu U, Wellhausen N, June CH. Young RM, et al. Among authors: june ch. Cancer Discov. 2022 Jul 6;12(7):1625-1633. doi: 10.1158/2159-8290.CD-21-1683. Cancer Discov. 2022. PMID: 35417527 Free PMC article.

2

Multiple injections of electroporated autologous T cells expressing a chimeric antigen receptor mediate regression of human disseminated tumor.

Zhao Y, Moon E, Carpenito C, Paulos CM, Liu X, Brennan AL, Chew A, Carroll RG, Scholler J, Levine BL, Albelda SM, June CH. Zhao Y, et al. Among authors: june ch. Cancer Res. 2010 Nov 15;70(22):9053-61. doi: 10.1158/0008-5472.CAN-10-2880. Epub 2010 Oct 5. Cancer Res. 2010. PMID: 20926399 Free PMC article.

3

In vivo persistence, tumor localization, and antitumor activity of CAR-engineered T cells is enhanced by costimulatory signaling through CD137 (4-1BB).

Song DG, Ye Q, Carpenito C, Poussin M, Wang LP, Ji C, Figini M, June CH, Coukos G, Powell DJ Jr. Song DG, et al. Among authors: june ch. Cancer Res. 2011 Jul 1;71(13):4617-27. doi: 10.1158/0008-5472.CAN-11-0422. Epub 2011 May 5. Cancer Res. 2011. PMID: 21546571 Free PMC article.

4

Chimeric Antigen Receptor Therapy for B-cell Malignancies.

Porter DL, Kalos M, Zheng Z, Levine B, June C. Porter DL, et al. J Cancer. 2011;2:331-2. doi: 10.7150/jca.2.331. Epub 2011 Jun 1. J Cancer. 2011. PMID: 21716851 Free PMC article.

5

Zoom Zoom: racing CARs for multiple myeloma.

Maus MV, June CH. Maus MV, et al. Among authors: june ch. Clin Cancer Res. 2013 Apr 15;19(8):1917-9. doi: 10.1158/1078-0432.CCR-13-0168. Epub 2013 Feb 26. Clin Cancer Res. 2013. PMID: 23444214 Free PMC article.

6

Chimeric antigen receptor-modified T cells for acute lymphoid leukemia.

Grupp SA, Kalos M, Barrett D, Aplenc R, Porter DL, Rheingold SR, Teachey DT, Chew A, Hauck B, Wright JF, Milone MC, Levine BL, June CH. Grupp SA, et al. Among authors: june ch. N Engl J Med. 2013 Apr 18;368(16):1509-1518. doi: 10.1056/NEJMoa1215134. Epub 2013 Mar 25. N Engl J Med. 2013. PMID: 23527958 Free PMC article.

7

Enhanced effector responses in activated CD8+ T cells deficient in diacylglycerol kinases.

Riese MJ, Wang LC, Moon EK, Joshi RP, Ranganathan A, June CH, Koretzky GA, Albelda SM. Riese MJ, et al. Among authors: june ch. Cancer Res. 2013 Jun 15;73(12):3566-77. doi: 10.1158/0008-5472.CAN-12-3874. Epub 2013 Apr 10. Cancer Res. 2013. PMID: 23576561 Free PMC article.

8

Regimen-specific effects of RNA-modified chimeric antigen receptor T cells in mice with advanced leukemia.

Barrett DM, Liu X, Jiang S, June CH, Grupp SA, Zhao Y. Barrett DM, et al. Among authors: june ch. Hum Gene Ther. 2013 Aug;24(8):717-27. doi: 10.1089/hum.2013.075. Hum Gene Ther. 2013. PMID: 23883116 Free PMC article.

9

Adoptive T cell transfer for cancer immunotherapy in the era of synthetic biology.

Kalos M, June CH. Kalos M, et al. Among authors: june ch. Immunity. 2013 Jul 25;39(1):49-60. doi: 10.1016/j.immuni.2013.07.002. Immunity. 2013. PMID: 23890063 Free PMC article. Review.

10

Chimeric antigen receptor therapy for cancer.

Barrett DM, Singh N, Porter DL, Grupp SA, June CH. Barrett DM, et al. Among authors: june ch. Annu Rev Med. 2014;65:333-47. doi: 10.1146/annurev-med-060512-150254. Epub 2013 Nov 20. Annu Rev Med. 2014. PMID: 24274181 Free PMC article. Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

604 results

Search Page